1 - 2 / 2 1 |
1. Anti-vimentin, anti-TUFM, anti-NAP1L1 and anti-DPYSL2 nanobodies display cytotoxic effect and reduce glioblastoma cell migration Alja Zottel, Ivana Jovchevska, Neja Šamec, Jernej Mlakar, Jernej Šribar, Igor Križaj, Marija Skoblar Vidmar, Radovan Komel, 2020, original scientific article Keywords: glioblastoma, glioblastoma stem cells, nanobodies, cell migration, cytotoxicity, vimentin, DPYSL2, NAP1L1, TUFM |
2. Large-scale transcriptomics-driven approach revealed overexpression of CRNDE as a poor survival prognosis biomarker in glioblastoma Maxim Sorokin, Mikhail Raevskiy, Alja Zottel, Neja Šamec, Marija Skoblar Vidmar, Alenka Matjašič, Andrej Zupan, Jernej Mlakar, Maria Suntsova, Denis V. Kuzmin, Anton A. Buzdin, Ivana Jovchevska, 2021, original scientific article Keywords: glioblastoma, noncoding RNA, long-term survival, CRNDE, RNA sequencing |